Mondelez beats core revenue estimates on emerging markets demand
April 30, 2019
Trump’s Fed pick Moore faces mounting lawmaker doubts
April 30, 2019

Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip

Eli Lilly and Co on Tuesday reported lower-than-expected first-quarter sales for its top-selling diabetes drug Trulicity, and the U.S. drugmaker said the need to offer rebates and discounts were taking a toll and likely to weigh on revenue growth for the year.

Powered by WPeMatico